Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 967,489 |
|
|||||
| News | - | ||||||
| Day High | 14.39 | Low High |
|||||
| Day Low | 13.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immunome Inc | IMNM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.53 | -3.72% | 13.73 | 17:14:14 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.28 | 13.70 | 14.39 | 13.73 | 14.26 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,408 | 967,489 | $ 13.93 | $ 13,478,915 | - | 4.44 - 30.958 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:03:45 | 25 | $ 13.90 | USD |
Immunome Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 586.68M | 42.73M | - | 14.02M | -106.81M | -2.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immunome News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMNM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.26 | 17.60 | 13.70 | 15.02 | 1,116,914 | -3.53 | -20.45% |
| 1 Month | 24.81 | 24.92 | 13.70 | 18.09 | 795,521 | -11.08 | -44.66% |
| 3 Months | 16.48 | 30.958 | 13.70 | 21.98 | 810,812 | -2.75 | -16.69% |
| 6 Months | 8.87 | 30.958 | 6.93 | 19.15 | 526,750 | 4.86 | 54.79% |
| 1 Year | 5.57 | 30.958 | 4.44 | 16.61 | 337,867 | 8.16 | 146.50% |
| 3 Years | 31.46 | 32.4476 | 2.09 | 15.82 | 190,950 | -17.73 | -56.36% |
| 5 Years | 15.66 | 63.78 | 2.09 | 17.74 | 185,911 | -1.93 | -12.32% |
Immunome Description
| Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. |
